Clinical
Barriers still blocking Diabetes MedsCheck program
While uptake of Diabetes MedsChecks is still low, pharmacists are finding benefits, but also shortfalls, in the program Barriers continue to inhibit the Diabetes MedsChecks (DMC) program from reaching more …
Mixed results from regulator
TGA rebuffs Guild on advertising schedule change, while pain relieving agent moves to S2 A manufacturer’s request to allow the advertising of preparations containing astrodrimer sodium has been rejected by …
Throat sprays downscheduled
Low-volume flurbiprofen throat sprays have been moved to open retail sale The Therapeutic Goods Administration’s medicines scheduling body has decided to move low volume flurbiprofen throat sprays to open sales, …
Shortage continues
TGA warns of continuing shortages of an arthritis treatment, but says the situation may be easing The Therapeutic Goods Administration (TGA) says there may be some light at the end …
Shortage warning
TGA issues warning over ongoing shortages of an arthritis treatment The Therapeutic Goods Administration today (23 February) issued a warning that Bristol-Myers Squibb Australia Pty Ltd had notified them of …
Missing medicines
Almost 20% of medications are unaccounted for in Australian hospital electronic administration records A new study has revealed alarming quantities of medications supplied to hospital wards and EDs are not …
Benzo, antidepressant use analysed
Delirium has been linked to preoperative use of specific antidepressants and benzodiazepines in a new case-control study, with a strong case for pharmacists to deprescribe People who use antidepressants and …
Schedules to stay the same
TGA rejects proposals to downschedule more ibuprofen products and Chinese medicine ingredients Proposals for the downscheduling of ibuprofen and some Chinese medicine ingredients have been rejected by the Therapeutic Goods …
More questions over label changes
Pharmacy groups have welcomed proposals to alter the advisory labels of a number of medicines, although questions have been raised over new indications for lidocaine The proposals are part of …
Hope for new mental health treatment options
MDMA and psilocybin may show promise for mental health treatment when administered in closely clinically supervised settings, independent panel finds MDMA and psilocybin may show potential as therapeutic agents for …